2010 Scrip 100 - The flu pandemic: mild at first, but could turn nasty
This article was originally published in Scrip
Executive Summary
The swine flu pandemic shook up national governments and their populations in 2009, but H1N1 proved to be a boon for manufacturers of antiviral products, notably Roche and GlaxoSmithKline. Meanwhile, other companies are planning new kinds of vaccines to cope with future flu outbreaks, reports Ian Schofield.